We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Vitamin D treatment for connective tissue diseases: hope beyond the hype?
- Authors
Reynolds, John A.; Bruce, Ian N.
- Abstract
The prevalence of vitamin D deficiency is increased among patients with CTDs. The active form of vitamin D (calcitriol) is a potent regulator of the immune system and may suppress inflammatory responses. This has led to claims that vitamin D may be a safe treatment, or a treatment adjunct, to reduce systemic inflammation in this patient population. It is important to note, however, that there is insufficient evidence from robust clinical trials to support these novel uses for vitamin D. In this review we examine the potential role of vitamin D as a treatment adjunct for CTDs. We will discuss how vitamin D may modulate the immune response and review the current evidence for using vitamin D to treat CTDs and their associated co-morbidities. We conclude that while there is much excitement about vitamin D in this context, further well-designed trials are needed to demonstrate its efficacy in the treatment of patients with CTDs.
- Subjects
THERAPEUTIC use of vitamin D; INFLAMMATION prevention; IMMUNE system physiology; CARDIOVASCULAR diseases; CONNECTIVE tissue diseases; SYSTEMIC lupus erythematosus; VITAMIN D; VITAMIN D deficiency
- Publication
Rheumatology, 2017, Vol 56, Issue 2, p178
- ISSN
1462-0324
- Publication type
Article
- DOI
10.1093/rheumatology/kew212